Kitson Sarah J, Evans D Gareth, Crosbie Emma J
Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
Department of Obstetrics and Gynaecology, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Cancer Prev Res (Phila). 2017 Jan;10(1):1-13. doi: 10.1158/1940-6207.CAPR-16-0224. Epub 2016 Dec 13.
Already the fourth most common cancer in women in the developed world, the incidence of endometrial cancer is increasing rapidly, in line with the increasing prevalence of obesity. Relatively few studies have been undertaken of risk-reducing interventions aimed at limiting the impact of the disease on both individuals and the health service. Those that have been performed have demonstrated only modest results due to their application in relatively unselected populations. A validated risk prediction model is therefore urgently required to identify individuals at particularly high risk of endometrial cancer who may benefit from targeted primary prevention strategies and to guide trial eligibility. On the basis of a systematic review of the literature, the evidence for inclusion of measures of obesity, reproduction, insulin resistance, and genetic risk in such a model is discussed, and the strength of association between these risk factors and endometrial cancer is used to guide the development of a pragmatic risk prediction scoring system that could be implemented in the general population. Provisional cutoff values are described pending refinement of the model and external validation in large prospective cohorts. Potential risk-reducing interventions are suggested, highlighting the need for future studies in this area if the increasing tide of endometrial cancer is to be stemmed. Cancer Prev Res; 10(1); 1-13. ©2016 AACR.
子宫内膜癌已是发达国家女性中第四大常见癌症,其发病率正迅速上升,与肥胖患病率的增加相一致。针对旨在限制该疾病对个体和医疗服务影响的降低风险干预措施的研究相对较少。已开展的那些研究由于在相对未经过筛选的人群中应用,仅取得了有限的成果。因此,迫切需要一个经过验证的风险预测模型,以识别可能从有针对性的一级预防策略中获益的子宫内膜癌高危个体,并指导试验入选资格。基于对文献的系统综述,本文讨论了在这样一个模型中纳入肥胖、生殖、胰岛素抵抗和遗传风险指标的证据,并利用这些风险因素与子宫内膜癌之间的关联强度来指导开发一个可在普通人群中实施的实用风险预测评分系统。在模型完善及在大型前瞻性队列中进行外部验证之前,描述了临时截断值。本文提出了潜在的降低风险干预措施,强调如果要遏制子宫内膜癌不断上升的趋势,该领域未来研究的必要性。《癌症预防研究》;10(1);1 - 13。©2016美国癌症研究协会。